Patients with refractory or high-risk myasthenia gravis (MG) respond poorly to conventional immunosuppressive therapy, requiring rescue therapies and often experiencing treatment toxicity. The study d...Show More
🎉 Join the #1 community of podcast lovers and never miss a great podcast.
Sign up
Recommendations